A lot of people come to this comparison with the same backstory. They were prescribed zopiclone or a benzodiazepine for a short period, it helped, and then it didn’t. Or the prescription was meant to last two weeks but ended up lasting two years. If you’re asking about sleeping pills vs medical cannabis in the UK, it’s usually because something about the current arrangement isn’t working. The frustrating part for many people is being told clearly that long-term sleeping pills aren’t a good idea, but then being given nothing to replace them with.
Key Takeaways
- Sleeping pills, including Z-drugs and benzodiazepines, are recommended for short-term use only, typically two to four weeks
- Long-term use of these medications carries documented risks, including tolerance, dependency, and cognitive effects
- Medical cannabis for sleep is a legally prescribable option for eligible patients where other treatments have not been adequate
- The evidence base for CBMPs in insomnia is still developing, but UK-specific real-world data is increasingly supportive
- Neither option is universally superior; the right choice depends on individual circumstances assessed by a clinician
How Sleeping Pills Work and Why They’re Designed for Short-Term Use?
The most commonly prescribed sleeping pills in the UK are Z-drugs, primarily zopiclone, and benzodiazepines such as temazepam. Both work by enhancing the action of GABA, a calming neurotransmitter in the brain, which reduces the time it takes to fall asleep and decreases nighttime waking.
They work. That’s not the issue. The issue is what happens with prolonged use.
NICE guidelines specifically state that Z-drugs are not recommended for long-term treatment of chronic insomnia because of tolerance and dependence risks.¹ The standard recommendation is two to four weeks. In practice, many patients take them for far longer.
Tolerance means higher doses may be needed over time to achieve the same effect. Dependency means the body adapts to the presence of the drug, and rebound insomnia, sometimes worse than the original, can occur when stopping. Side effects with long-term Z-drug use can include next-day drowsiness, impaired memory, and an increased fall risk, particularly in older patients.² There is also the question of sleep quality. Z-drugs and benzodiazepines are known to suppress REM sleep, the stage most associated with emotional processing and feeling genuinely rested. You may sleep a full night and still wake feeling like you haven’t. Cognitive behavioural therapy for insomnia (CBT-I) is considered more effective for long-term outcomes than sleeping pills by the available evidence.³
Where Medical Cannabis Fits as an Alternative to Zopiclone?
Medical cannabis for sleep in the UK works differently. When prescribed through a licensed clinic, it takes the form of a cannabis-based product for medicinal use, or CBPM. This is a pharmaceutical-grade prescription medicine, not a CBD supplement or anything available over the counter. Rather than sedating the brain through GABA pathways, cannabinoids interact with the endocannabinoid system, which plays a natural role in sleep-wake regulation.
THC may reduce the time it takes to fall asleep and decrease night-time waking. CBD appears to support sleep through a different mechanism, by inhibiting the breakdown of the body’s own sleep-promoting compounds rather than introducing an external sedative signal. This distinction matters because the risk profile differs from that of Z-drugs.
Sleeping pills vs medical cannabis is not a straightforward comparison where one clearly wins. THC-containing medical cannabis carries its own considerations. Tolerance to the sleep-related effects of THC can develop with continuous use over time. Some patients experience next-day effects depending on dose and timing. High-THC formulations are not suitable for everyone and are assessed carefully in individuals with certain mental health histories.
One concern that comes up often, particularly for people already exhausted from poor sleep, is whether medical cannabis will leave them feeling groggy or foggy the next morning. It’s a fair question. The answer depends largely on the formulation. CBD-dominant products and lower-THC options are generally associated with less next-day sedation than higher-THC formulations. Timing also matters. A prescribing clinician will factor in when you take your medication, your sensitivity, and whether you drive or need to be alert early in the morning. If morning grogginess does become an issue after starting treatment, it doesn’t mean the treatment stops. It means the formulation or timing gets adjusted. That flexibility is built into the care model.
The key difference is that medical cannabis is prescribed within a structured care model with regular monitoring, with the formulation adjusted as needed based on your response. Sleeping pills, particularly when used long-term, are often continued with less active oversight. In practice, what that oversight looks like at LeafEase is a structured follow-up schedule where your clinician reviews how the treatment is working, whether the formulation needs adjusting, and whether the dose remains appropriate over time. If something isn’t working well enough, it gets changed. That kind of active management is rarely part of a long-term repeat prescription for zopiclone.
What the Evidence Comparison Actually Looks Like?
CBT-I remains the first-line recommendation for chronic insomnia based on current clinical guidance. Where CBT-I and medication have both failed or are inaccessible, medical cannabis is one of the alternatives to zopiclone that can now be considered under UK clinical frameworks. LeafEase’s sleeping disorders page covers the conditions assessed and what treatment may involve.
A 2025 study from the UK Medical Cannabis Registry found that over 40% of insomnia patients who completed a six-month assessment reported clinically significant improvements in sleep quality following CBPM treatment.⁴ An updated 18-month analysis published the same year found sustained improvements, with patients over 50 responding particularly well.⁵
No head-to-head randomised controlled trials comparing sleeping pills directly with CBMPs for insomnia exist in the UK. So while the real-world evidence for medical cannabis is encouraging, direct superiority over conventional sleep medications cannot be claimed. What can be said is that for patients who have tried sleeping pills long-term and found them unsustainable, medical cannabis represents a clinically supervised alternative worth discussing with a specialist.
Z-Drugs vs Medical Cannabis: A Quick Comparison
For anyone weighing up their options, this table summarises the key differences between Z-drugs and cannabis-based medicines for insomnia based on current clinical evidence.
| Z-drugs (e.g. zopiclone) | Medical cannabis (CBPMs) | |
| How it works | Sedates the brain by enhancing GABA, a calming chemical | Works with the body’s own sleep-regulating system via cannabinoid receptors |
| Recommended duration | Two to four weeks | Ongoing, reviewed regularly by a specialist |
| Dependency risk | Documented risk with extended use | Lower dependency risk, though tolerance to THC can develop over time |
| Effect on REM sleep | Suppresses REM sleep, often reducing sleep quality | Varies by formulation; CBD-dominant options have a more neutral effect |
| Clinical monitoring | Typically issued on repeat prescription with limited review | Regular follow-up consultations built into the treatment model |
This is a general comparison based on available evidence. Individual responses vary and a specialist clinician will assess which approach is appropriate for your specific circumstances.If you’ve been relying on sleeping pills longer than you’d like and haven’t found a better solution, you can check your eligibility for medical cannabis to see whether a specialist consultation is a suitable next step.
This article is for informational purposes only and does not constitute medical advice. Medical cannabis treatment requires a consultation with a qualified specialist clinician. To find out whether you may be eligible, visit leafease.co.uk.
Frequently Asked Questions
Can I switch from zopiclone to medical cannabis?
This is something a specialist would assess based on your full history. Switching from a Z-drug typically involves a tapering plan for the zopiclone, as abrupt discontinuation can cause rebound insomnia and other withdrawal effects. A prescribing clinician would take your current medication into account before issuing a CBPM prescription.
Are sleeping pills or medical cannabis safer for long-term use?
Long-term use of Z-drugs and benzodiazepines carries documented risks including tolerance, dependency, and cognitive effects. The long-term safety profile of medical cannabis is still being studied, though UK registry data to date shows predominantly mild adverse events. Neither is approved as an indefinite long-term solution without clinical monitoring.
Do sleeping pills affect sleep quality differently from medical cannabis?
Yes, as covered above, Z-drugs suppress REM sleep in a way that affects overall sleep quality. THC-containing medical cannabis may also affect sleep architecture depending on dose and formulation. CBD-dominant options tend to have a more neutral effect on sleep stages.
Can I get medical cannabis for insomnia without trying sleeping pills first?
You would need to demonstrate that at least two previous treatments have been tried without adequate benefit. This could include CBT-I, sleep hygiene interventions, melatonin, or medication. The specific history required will be assessed by the specialist during your consultation.
Will medical cannabis make me drowsy the next day?
This depends on the formulation, the dose, and how your body responds. Some patients do experience next-day drowsiness, particularly early in treatment or with higher-THC formulations. Your prescribing clinician will factor in your lifestyle, any driving requirements, and your sensitivity when recommending a starting dose.
I already woke up exhausted. Will medical cannabis make that worse?
This is one of the most common concerns among people who’ve been living with poor sleep for a long time. The short answer is that it depends on the formulation, and getting the formulation right is exactly what the prescribing process is designed to do. CBD-dominant products are less likely to cause next-day sedation than higher-THC options. Your clinician will ask about your morning routine, whether you drive, and how sensitive you are to medication before recommending a starting point. If the first formulation doesn’t feel right, it gets reviewed and adjusted. The goal is better sleep and a clearer morning, not a trade-off between the two.
Is melatonin a better alternative to both sleeping pills and medical cannabis?
Melatonin is available over the counter in the UK as a food supplement, though higher-dose versions do require a prescription. It works best for circadian rhythm disruption, such as jet lag or shift work, rather than chronic insomnia. It doesn’t carry the dependency risk of Z-drugs, but the evidence for long-standing insomnia is limited. As a supplement it sits in a different category from prescription medicines entirely. Where melatonin and other treatments haven’t worked adequately, medical cannabis, as a clinically supervised prescription treatment, may be considered by a specialist.
References
[1] National Institute for Health and Care Excellence (2019, reviewed 2025) Cannabis-based medicinal products. NICE Guideline NG144. Available at: https://www.nice.org.uk/guidance/ng144 [Accessed: April 2026].
[2] Drugs.com (2025) Zopiclone: uses, dosage, side effects, warnings. Available at: https://www.drugs.com/zopiclone.html [Accessed: April 2026].
[3] Sleep Station (2025) Zopiclone and sleep: should you take it for insomnia? Available at: https://www.sleepstation.org.uk/articles/medicines/zopiclone/ [Accessed: April 2026].
[4] Vivek, K., Karagozlu, Z., Erridge, S., et al. (2024) UK Medical Cannabis Registry: Assessment of clinical outcomes in patients with insomnia. Brain and Behavior, 14(2), e3410. https://doi.org/10.1002/brb3.3410
[5] Aggarwal, A., Erridge, S., Cowley, I., et al. (2025) UK Medical Cannabis Registry: A clinical outcomes analysis for insomnia. PLOS Mental Health, 2(8). https://doi.org/10.1371/journal.pmen.0000390
